VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference
VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference
VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016
VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update
VolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update
VolitionRx Limited and Hvidovre Hospital Begin Large Prospective Clinical Study
VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter
Triage Blood Test Data Presented to Leading International Experts at the World Endoscopy Organization's Colorectal Cancer Screening Committee
Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25%
